⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27619461 | 0.80 | — | — | |
| SCHEMBL30549543 | 0.80 | — | — | |
| SCHEMBL28865045 | 0.75 | — | — | |
| SCHEMBL27030844 | 0.71 | — | — | |
| SCHEMBL5888231 | 0.69 | — | — | |
| SCHEMBL3509135 | 0.66 | — | — | |
| SCHEMBL1069823 | 0.65 | — | — | |
| SCHEMBL580952 | 0.65 | — | — | |
| SCHEMBL8508689 | 0.65 | — | — | |
| SCHEMBL6427949 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094689-A | Combination therapy of diacylglycerol kinase (DGK) alpha inhibitors with other therapies | — | 2026-05-26 | — | — | CN | disclosed |
| CN-120166922-A | Apyrase inhibitors | 德州作物科学股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120019049-A | Azole modulators of cholesterol biosynthesis and their use for promoting remyelination | 基因泰克公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119998288-A | Hydantoin modulators of cholesterol biosynthesis and their use for promoting remyelination | 基因泰克公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119968359-A | TEAD inhibitors and methods of use thereof | 英矽智能科技知识产权有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119855586-A | Compositions and methods for treating metabolic disorders | 加利福尼亚大学董事会 | 2025-04-18 | — | — | CN | disclosed |
| CN-119790050-A | Oxazole TRPML1 agonists and uses thereof | 利布拉医疗公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119654318-A | Compounds and pharmaceutical compositions for degrading SWI/SNF-associated matrix-associated actin-dependent chromatin subfamily A modulators | 普莱克斯姆公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119630634-A | Method for preparing modulators of eukaryotic initiation factor 2B | 戴纳立制药公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119604512-A | TYK2 inhibitor and application thereof | 阿鲁米斯股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-116507626-A | Compositions and methods for modulating short-chain dehydrogenase activity | 罗迪奥治疗公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116406364-A | Tetrahydroisoquinoline derivatives for the treatment of erythrocyte disorders and inflammatory diseases | 赛诺菲公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-116234803-A | Combinations of estrogen receptor degrading agents and cyclin-dependent kinase inhibitors for the treatment of cancer | 冰洲石生物科技公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-116194112-A | Pyridine-1, 5-diones exhibiting MNK inhibition and methods of use thereof | 4E治疗公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-116113637-A | E-selectin targeting agents | 糖模拟物有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-115605478-A | Compounds and methods of use | 埃克塞里艾克西斯公司（US） | 2023-01-13 | — | — | CN | disclosed |
| CN-114591335-A | Indazole compound and preparation method and application thereof | 浙江大学 | 2022-06-07 | — | — | CN | disclosed |
| CN-112028877-B | Alkoxy pyridone compound and preparation method and application thereof | 江西济民可信集团有限公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-112028877-A | Alkoxy pyridone compound and preparation method and application thereof | 江西济民可信集团有限公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-111683932-A | Compound with BET inhibition activity, preparation method and application thereof | 上海海和药物研究开发有限公司 | 2020-09-18 | — | — | CN | disclosed |